Ventricular tachycardia in structurally normal hearts

被引:7
作者
Wall T.S. [1 ]
Freedman R.A. [1 ]
机构
[1] University of Utah Medical Center, Division of Cardiology, Salt Lake City, UT 84132
关键词
Ventricular Tachycardia; Catheter Ablation; Right Ventricular Outflow Tract; Brugada Syndrome; Right Bundle Branch Block;
D O I
10.1007/s11886-002-0038-0
中图分类号
学科分类号
摘要
This review focuses on four distinct syndromes of ventricular tachycardia that occur in the structurally normal heart. Recent advances in the fields of molecular biology and genetics, along with intracardiac mapping techniques, have led to a greater understanding of the underlying mechanisms of and therapeutic options for these syndromes. The cyclic AMP-mediated triggered activity tachycardias, including exercise-induced right ventricular outflow track tachycardia and repetitive monomorphic ventricular tachycardia, are the most common of these syndromes. Idiopathic left ventricular tachycardia, for which there is significant evidence for re-entry within the Purkinje network, is largely curable with catheter ablation. The long QT syndrome comprises a heterogeneous group of ion channel defects leading to prolongation of myocyte repolarization and Torsade de Pointes ventricular tachycardia. Brugada syndrome, a familial disorder of transmembrane ion transport, is felt to be the result of a group of sodium channel defects leading to characteristic electrocardiographic abnormalities, and syncope and sudden death. Primary focus is given to recent advances in our understanding of the underlying mechanism and current therapeutic approaches. © 2002 by Current Science Inc.
引用
收藏
页码:388 / 395
页数:7
相关论文
共 49 条
[21]  
Khan I.A., Long qt syndrome: Diagnosis and management, Am Heart J, 143, pp. 7-14, (2002)
[22]  
Splawski I., Spectrum of mutations in long qt syndrome genes. Kvlqt1, herg, scn5a, kcne1, and kcne2, Circulation, 102, pp. 1178-1185, (2000)
[23]  
Mitcheson J.S., A structural basis for drug-induced long qt syndrome, Proc Natl Acad Sci U S A, 97, pp. 12329-12333, (2000)
[24]  
Tzivoni D., Treatment of torsade de pointes with magnesium sulphate, Circulation, 77, pp. 392-397, (1988)
[25]  
Baile D.S., Magnesium suppression of early after depolarizations and ventricular arrhythmias induced by caesium in dogs, Circulation, 77, pp. 1395-1402, (1988)
[26]  
Zareba W., Influence of genotype on the clinical course of the long-qt syndrome, N Engl J Med, 339, pp. 960-965, (1998)
[27]  
Vincent G.M., The spectrum of symptoms and qt intervals in carriers of the gene for the long qt syndrome, N Engl J Med, 327, pp. 846-852, (1992)
[28]  
Moss A.J., Effectiveness and limitations of beta-blocker therapy in congenital long qt syndrome, Circulation, 101, pp. 616-623, (2000)
[29]  
Eldar M., Permanent cardiac pacing in patients with the long qt syndrome, J Am Coll Cardiol, 10, pp. 600-607, (1987)
[30]  
Moss A.J., Efficacy of permanent pacing in the management of high-risk patients with long qt syndrome, Circulation, 84, pp. 1524-1529, (1991)